BLAU3 logo
BLAU3
Blau Farmacêutica

Future Production Expansions Will Support Latin American Healthcare Demand

Published
13 Apr 25
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
R$16.09
23.7% undervalued intrinsic discount
14 Aug
R$12.28
Loading
1Y
-6.2%
7D
0.2%

Author's Valuation

R$16.1

23.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates3

Shared on01 May 25
Fair value Decreased 3.03%

Read more

Shared on23 Apr 25
Fair value Decreased 0.36%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on17 Apr 25
Fair value Decreased 0.45%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more